Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial - Heerspink, H J; Kiyosue, A; Wheeler, D C (Lancet, 2023)